Next steps
Gabriel
What are your specific (measurable) short term (6 mo) goals?
 	- We will have a new regulatory policy, select who are doing?, how do it?, what are do?
- Technology. Complete humanized antibody
- Pitch and documents for first roundtable investors
What is your time line (6 mo)?  List specific dates by which you aim to complete goals and sub-goals.
 	- 
Three months for regulatory police 
- 
Six months for humanized antibodies 
- 
Three months for investors documents 
Ramon
What are your specific (measurable) short term (6 mo) goals?
 	- We need to establish our policy to reach regulatory requirements (What and how to do)
- To humanize our mAb.
- Pitch and documents for first roundtable investors.
What is your time line (6 mo)?  List specific dates by which you aim to complete goals and sub-goals.
 	- 
For goal 1, 3 months 
- 
For goal 2, 6 months 
- 
For goal 3, 3 months 
Assumptions
Gabriel
What are the key assumptions you have identified? (List at least 3).
 	- Antibody action will have the same action mode than mouses
- Antibody will not have toxicity (humans)
- IP will completely accept
- We rise up the amount for address the project
- New treatment for psoriasis
Ramon
What are the key assumptions you have identified? (List at least 3).
 	- Necessity of new treatments for psoriasis
- The humanized mAb will have the same effects that the murine one.
- Absence of Toxicity of the humanized mAb
- We will complete regulatory requirements.
- Our Patent will be accepted
- We will find all financial support to reach phase I

cof
Statement
Gabriel
Psoriasis  patients reluctant to current treatments  need a diferent aproach to inmunosupresant therapy. Bambi will be a new therapeutic target antibody based in a new  metabolism route
Ramon
A significant number of psoriatic patients do not respond properly to existing therapies.
We have identified BAMBI as a new key molecule involved in disease and its inhibition with our anti-BAMBI mAb blocks disease in animals.
We plan to humanize this mAb and explore its therapeutic effect un clinical trials with humans.
Reflections
As I mentioned in my presentation, I'm a scientist coming from academia without a previous experience in business.  Then, my perception of our project was very far from the perception that I have now. I learned that communication, focussing is essential to increase the value of our project.
I clarify the momento of Inhibitec project. 
Focus the project.
Focus the pitch 
We spend three days, we do a task of three months.
Very intensive. Very useful.